Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Aytu BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer PYSZCZYMUKA GREG
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director JAIN ABHINAV
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Disbrow Jarrett
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director JAIN ABHINAV
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director LIU VIVIAN H
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Donofrio John Jr.
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director DOCKERY CARL
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Disbrow Joshua R.
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer BROOKE CHRISTOPHER
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Oki Mark K
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer PYSZCZYMUKA GREG
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Aytu BioPharma | 3: Initial statement of beneficial ownership of securities-10% Owner Nantahala Capital Management, LLC
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Aytu BioPharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(19.7%),Wilmot B. Harkey(19.7%), etc.
Aytu BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals
No Data